Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing. - Wikidata - wikimedia - TriplyDB

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

http://www.wikidata.org/entity/Q35032007

about

Clinical tumor sequencing: opportunities and challenges for precision cancer medicine ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions Advancing clinical oncology through genome biology and technology.GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.Genomic Characterization of Upper Tract Urothelial Carcinoma Targeted exome sequencing profiles genetic alterations in leiomyosarcoma.Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.NF1 Mutations Are Common in Desmoplastic Melanoma.Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.Institutional implementation of clinical tumor profiling on an unselected cancer population.Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers.Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.EBV-associated lymphoepithelioma-like carcinoma of the pancreas: Case report with targeted sequencing analysis.Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).Genomic characterization of response to chemoradiation in urothelial bladder cancer.Activating mutation of PDGFRB gene in a rare cardiac undifferentiated intimal sarcoma of the left atrium: a case report.

P2860

Q27027942-917A519E-90F0-4123-B675-0276B542C020 Q27852637-61181CDA-E9D1-4385-A6B5-11A53825458A Q27852975-74528E48-8F9F-4425-9FA9-77F4522369EC Q27853093-21F5CFF6-5D63-4975-BB3D-E75426CDF0B9 Q27853245-D052F621-BA4D-4CC1-BAB3-3E529408EA4B Q30783484-D980E791-6DE6-43A0-8623-59313183635C Q30874026-458F9FA8-B3E9-4749-8A51-1AF62C14906A Q33415584-AF09F7D4-1496-4727-AC9A-599049AD132F Q33663019-846EB4C3-8D35-48CD-8EA5-44B55DFEEC75 Q34304263-F8663CE1-5207-4DB5-B847-1C7D7863B406 Q34803010-48E7C333-28AF-4EA2-B46E-1E57484B9059 Q35537214-AC3B89F5-66B6-436E-A734-C9A23F7424F5 Q35584856-9446EFB3-6951-493F-8FD7-C9EA2641D13C Q35606985-3EFAB1FE-1CF2-41F2-BFF3-78562A901D0D Q36014165-0D76442C-55D1-4954-B998-936B26BE6936 Q36070539-B3E9D166-8E15-44CF-AF02-12B76F558EBE Q36273267-348AF5C8-3CBB-44AF-A972-2102B442ADFA Q36274943-5B670D8F-EC86-4096-85C0-1F67BFFC08A0 Q36362571-22098D5D-6999-4A83-928C-8ED2DA6E5C87 Q36470353-769E377E-DB28-43AA-B118-86EA776E1C78 Q36726792-FF62E411-4D8F-4BFE-B43D-082FF4B5F108 Q36844915-4F3C2AF9-A4B8-4CB6-B0BA-5A17BB848637 Q37193365-10C7558F-D11F-412D-810C-774CAD871914 Q37248485-9CF781C7-A9D8-4F85-B621-4E9567CABC37 Q37286915-AFE1421D-C1D6-4EA2-9324-EE02585450BE Q37330688-CB32C113-8595-442E-89F6-D948EF963D0B Q37417570-595D6D69-948D-4C7F-BF85-4256DE572212 Q37699579-B17E2311-A103-46FC-932A-2A3C34A9685B Q38719280-89E8A3F8-08FC-4EAA-B088-443FB1549B3A Q38725360-DD17CF3E-DA1C-4902-8DD5-C98604884007 Q38792051-D8133806-8872-4C83-B3FD-499C6EB8F056 Q38954754-420185AD-35B7-4E53-B0A0-A9FB8D9AE2B2 Q40275671-F688A9D5-6164-40D5-A990-3905CB854D80 Q40605762-26085574-309D-4A1D-A2C6-782683F6D9EF Q41105157-FC82F336-713B-4985-A7DE-904C6B5C9D47 Q41131760-CD8AC2A6-9547-4D88-A037-77F488534AE9 Q41838545-57BFC3E2-E0EB-4CD3-9530-23E17911F921 Q41928624-142F9355-6847-4717-BF65-4B7D7D6539BF Q44338887-4883A25D-D4E6-4323-BC33-F2509DABA066 Q47159879-8A3240E1-CC60-4092-834B-1C9AA51415E7

P2860

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

http://www.wikidata.org/entity/Q35032007

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Detecting somatic genetic alte ...... massively parallel sequencing.

@ast

Detecting somatic genetic alte ...... massively parallel sequencing.

@en

type

label

Detecting somatic genetic alte ...... massively parallel sequencing.

@ast

Detecting somatic genetic alte ...... massively parallel sequencing.

@en

prefLabel

Detecting somatic genetic alte ...... massively parallel sequencing.

@ast

Detecting somatic genetic alte ...... massively parallel sequencing.

@en

P1433

Q35032007-54DA6306-B2EF-46A5-8E0D-E1A18933C9C7

P1476

Q35032007-3C173682-44CD-4D45-BE07-C42C5ED8509A

P2093

Q35032007-0BFB8D1E-4587-42A3-AF70-1E8CED75A0BE

Q35032007-2428B9FD-F447-463C-91DE-DAD8FACDFEE2

Q35032007-358E1A16-2739-4D6D-B0EC-7247798631A1

Q35032007-3B40212E-9363-4160-A5E7-A0C313FE22AC

P2860

Q35032007-1E9B5357-B671-4B62-AEA8-D1AE59E5641E

Q35032007-258A2848-3480-4481-B83C-8DB4A8D6317B

Q35032007-284BD676-E3AF-4B65-8310-14CCCDAE98FC

Q35032007-3C8B7F6C-E771-494B-8393-E4CBE2CA45B5

Q35032007-44EF8095-6DF9-4B3F-AAC8-E0916ECBA119

Q35032007-483F2345-044F-42B3-95A0-A6A1610CC431

Q35032007-4A8F46E3-475F-4D76-826E-28577A07BE74

Q35032007-53415099-8F44-4376-8990-15C8C14BE802

Q35032007-76CE6131-5F91-403A-B8E4-A8F2590D8B00

Q35032007-82DF83FE-A4F3-46D3-9B5E-9657E37E65BA

P304

Q35032007-52A71BE5-8DF5-4F36-BE84-2B9B74B2D3F0

P31

Q35032007-368015E1-E4B5-4281-82A4-BC8B83BA3B11

P356

Q35032007-5DAEB985-C06C-4094-A2A8-FB9D41FDB771

P433

Q35032007-962A47F1-B843-4A19-9F00-7404CA2F6C9C

P50

Q35032007-3BF33F44-4B16-4A07-AE39-EC68EE65D5B1

Q35032007-D6AFC7DE-3CA8-4070-B9E3-28F996C93198

P577

Q35032007-8B21B8F4-2680-47DC-9E58-ABBE30B33B5F

P5875

Q35032007-651A2536-6692-4D20-8E1C-50912AB10832

P698

Q35032007-0819734C-1A17-4A81-8BE7-D31A3FE0C2C0

P932

Q35032007-0E6DBF59-7B8C-444A-9F85-347BA0CED60D

P356

P1433

Journal of Visualized Experiments

P1476

Detecting somatic genetic alte ...... massively parallel sequencing

@en

P2093

A Rose Brannon

http://www.w3.org/2001/XMLSchema#string

Helen H Won

http://www.w3.org/2001/XMLSchema#string

Michael F Berger

http://www.w3.org/2001/XMLSchema#string

Sasinya N Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Profiling critical cancer gene mutations in clinical tumor samples

RNA-Seq: a revolutionary tool for transcriptomics

Fast and accurate short read alignment with Burrows-Wheeler transform

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges

A framework for variation discovery and genotyping using next-generation DNA sequencing data

Integrative genomics viewer

The cancer genome

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing

Advances in understanding cancer genomes through second-generation sequencing

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

P304

e50710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3791/50710

http://www.w3.org/2001/XMLSchema#string

P433

80

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258314289

http://www.w3.org/2001/XMLSchema#string

P698

24192750

http://www.w3.org/2001/XMLSchema#string

P932

3947962

http://www.w3.org/2001/XMLSchema#string